Cullinan Associates’s MILESTONE SCIENTIFIC INC (NEW) MSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-44,900
Closed -$2.42M 191
2018
Q1
$2.42M Buy
44,900
+2,200
+5% +$119K 0.18% 108
2017
Q4
$2.24M Buy
42,700
+15,300
+56% +$803K 0.16% 110
2017
Q3
$1.32M Buy
27,400
+200
+0.7% +$9.63K 0.1% 131
2017
Q2
$1.21M Buy
27,200
+1,800
+7% +$80.2K 0.09% 137
2017
Q1
$1.09M Sell
25,400
-3,850
-13% -$165K 0.09% 141
2016
Q4
$1.24M Sell
29,250
-500
-2% -$21.1K 0.11% 133
2016
Q3
$954K Sell
29,750
-2,250
-7% -$72.2K 0.08% 141
2016
Q2
$831K Hold
32,000
0.07% 142
2016
Q1
$800K Buy
32,000
+4,900
+18% +$123K 0.07% 141
2015
Q4
$862K Sell
27,100
-400
-1% -$12.7K 0.08% 136
2015
Q3
$866K Sell
27,500
-6,080
-18% -$191K 0.08% 148
2015
Q2
$1.3M Sell
33,580
-2,800
-8% -$109K 0.11% 132
2015
Q1
$1.3M Buy
36,380
+2,600
+8% +$92.8K 0.1% 133
2014
Q4
$1.31M Buy
33,780
+1,000
+3% +$38.8K 0.14% 72
2014
Q3
$1.13M Buy
+32,780
New +$1.13M 0.13% 74
2014
Q2
Sell
-24,380
Closed -$760K 96
2014
Q1
$760K Buy
+24,380
New +$760K 0.09% 80

Cullinan Associates's MSS Position: Q2 2018 in Review

Cullinan Associates sold out of MILESTONE SCIENTIFIC INC (NEW) (MSS) in Q2 2018, closing a stake of 44,900 shares — an estimated $2.42M sold.

Cullinan Associates first reported a position in MSS in Q1 2014 and held it in 16 quarters. The position peaked at $2.42M in Q1 2018. 0 funds tracked by Wall St. Rank hold MSS as of Q2 2018.

  • Cullinan Associates reported no remaining MILESTONE SCIENTIFIC INC (NEW) position as of Q2 2018 after selling out during the quarter.
  • Cullinan Associates sold 44,900 MILESTONE SCIENTIFIC INC (NEW) shares in Q2 2018, an estimated $2.42M.
  • Cullinan Associates first reported a position in MILESTONE SCIENTIFIC INC (NEW) in Q1 2014 and held it in 16 quarters.
  • Cullinan Associates's MILESTONE SCIENTIFIC INC (NEW) position peaked at $2.42M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held MILESTONE SCIENTIFIC INC (NEW) as of Q2 2018.

Based on Cullinan Associates's 13F filing for Q2 2018, filed 9 Jul 2018.